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NMDP, NETCORD AGREE TO LINK
CORD BLOOD SEARCH DATABASES
A new partnership between the In-
ternational NetCord Foundation (Net-
Cord) and the National Marrow Do-
nor Program (NMDP) Center for Cord
Blood will offer expanded access and
efficiency for transplant center teams
treating more than 35,000 people di-
agnosed with life-threatening blood
diseases each year.
The NetCord database, located in
Germany, currently has records of
more than 115,000 cord blood units,
representing the inventory of 24
blood banks in 17 countries. The
NMDP Center for Cord Blood pro-
vides access to over 50,000 units
from 16 banks within its network, the
largest listing of cord blood units in
the United States.
A new ability to simultaneously ac-
cess both registries on behalf of pa-
tients will allow transplant centers to
more efficiently determine whether a
potential match exists within one of
the registries’ cord blood banks.
Search Exchange
Through the partnership, NetCord
and NMDP will exchange search re-
ports that list potential matches of
cord blood units for individual pa-
tients. A search for a match can be
initiated online through either the
NMDP or NetCord portals by trans-
plant physicians or coordinators. All
preliminary searches submitted to ei-
ther NetCord or NMDP will receive
cord blood search results from both
registries, thereby eliminating the
need to enter searches in both sys-
tems.
“The new partnership is based on
our shared dedication to helping pa-
tients who are in critical need of a
cord blood transplant,” said Jeffrey
W. Chell, MD, chief executive officer
of NMDP. “By providing a new, high
level of efficiency to access cord
blood units from more than 40 banks
worldwide, transplant centers will
now have a streamlined process for
finding the best potential match for
their patients.”
According to Peter Wernet, MD,
president of NetCord, “This is only the
beginning for patients who are in
desperate need of a transplant as we
explore ways to expand our partner-
ship to access potentially life-saving
treatment options. The partnership
provides physicians and their patients
with access to a diverse listing of cord
blood units, which is critical to finding
a successful match.”
E-Mail Delivery
Search results requested by trans-
plant centers will be delivered via e-
mail. Transplant centers can work di-
rectly with the banks, or the NMDP
can facilitate testing and procure-
ment of cord blood units, and coor-
dinate communications, payments
and adherence to regulatory require-
ments for importing or exporting cel-
lular products. The NMDP also can
facilitate obtaining cord blood units
for U.S. transplant centers from either
organization’s banks and will con-
tinue to facilitate international trans-
plant centers to obtain cord blood
units from the NMDP Network banks.
GUIDELINES ARE UPDATED FOR
TRANSPLANT CONSULTATION TIMING
The National Marrow Donor Pro-
gram (NMDP) and ASBMT have is-
sued an update of the Guidelines on
Recommended Timing for Transplant
Consultation.
The recommendations identify
prognostic factors for patients at risk
of disease progression using standard
therapy, and suggest which patients
should be evaluated for transplanta-
tion by disease. The guidelines are
based on current clinical practice, the
medical literature and recent ASBMT
evidence-based reviews. They are in-
tended for use in patient counseling
and initial discussion during develop-
ment of a treatment plan that may
include transplantation.
The updated guidelines also are in-
cluded in an online Physician Re-
source Center maintained on the
NMDP Web site. The online center
provides information on recent ad-
vances in transplantation, outcomes
data and practical guidance on when
and how to refer a patient for trans-
plant consultation. The site also in-
cludes medical education and other
services for physicians who have pa-
tients who are potential candidates
for hematopoietic cell transplanta-
tion, including unrelated donor or
cord blood transplant.
PATIENTS SERVED BY NMDP
GREW BY 20% IN PAST YEAR
The number of patients served by
the National Marrow Donor Program
and its network increased by more
than 20 percent in the past year.
NMDP-facilitated marrow and cord
blood transplants exceeded 3,200 dur-
ing the fiscal year ending Sept. 30.
Cord blood shipments through
NMDP more than doubled for the
year, now representing 14 percent of
total transplants.
The number of minority patients
served by the NMDP increased signif-
icantly in 2006, growing by more
than 18 percent.
The percentage of patient searches
that proceed to transplant also in-
creased this year, while the average
time to find a matched donor de-
clined.
IRVING WEISSMAN TO PRESENT
THOMAS LECTURE AT KEYSTONE
Irving Weissman, MD, director of
the Institute of Stem Cell Biology and
Regenerative Medicine at Stanford
School of Medicine, will present the E.
125
Donnall Thomas Lecture at the BMT
Tandem Meetings in Keystone. His
presentation, “Normal and Neoplastic
Stem Cells,” will be on Saturday, Feb.
10.
Dr. Weissman is professor of pa-
thology and developmental biology
at Stanford School of Medicine. His
research encompasses the phylogeny
and developmental biology of hema-
topoietic cells. His laboratory identi-
fied and isolated the blood-forming
stem cell from mice, and has defined
by lineage analysis the stages of de-
velopment between the stem cells
and mature progeny such as granu-
locytes and macrophages. This re-
quired developing and cloning stro-
mal cells of the hematolymphoid
microenvironments – from the bone
marrow for myeloid and B-cells, and
from the thymus for T-cells.
Although the adhesion molecules
and factors from these stromal cells
proved important as molecules (and
the genes that encode them) for my-
eloid and B-cells, the analysis of T-cell
development required in vivo studies
of thymic development. In addition,
the Weissman laboratory has pio-
neered the study of the genes and
proteins involved in cell adhesion
events required for lymphocyte hom-
ing to lymphoid organs in vivo, either
as a normal function or as events in-
volved in malignant leukemic metas-
tases.
The Weissman laboratory also has
developed a model organism for lab-
oratory and field study of allorecogni-
tion – the invertebrate counterpart of
transplantation immunity. Working
with the protochordate Botryllus
schlosseri, which has a chordate lar-
val stage and an invertebrate adult
form, a single major gene locus has
been identified that governs rapid al-
lorecognition, and 2-3 other loci in-
volved in delayed allorecognition
events. This model is being used to
study the genes, proteins and cells
that govern protochordate allorecog-
nition, and the effects of these genes
on their population dynamics in the
field.
Dr. Weissman is recipient of the Li-
nus Pauling Medal for Outstanding
Contributions to Science from Stan-
ford School of Medicine, and the
Medal for Distinguished Contribu-
tions to Biomedical Research from the
New York Academy of Science. He is
an elected member of the National
Academy of Sciences and has been a
member of ASBMT since just after its
founding in 1995.
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